Also, insider Leon J. Topalian sold 2,626 shares of the business's stock in a transaction dated Monday, July 24th. Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) has declined 67.27% since September 14, 2016 and is downtrending. It has underperformed by 47.68% the S&P500.
Equities researchers at Macquarie initiated coverage on shares of Nucor Corporation (NYSE:NUE) in a research note issued on Wednesday, September 6th, MarketBeat.com reports. Therefore 58% are positive. Nucor Corporation has a one year low of $45.18 and a one year high of $68.00. They now have a United States dollars 60 price target on the stock. Nucor Corporation had 58 analyst reports since July 22, 2015 according to SRatingsIntel. Standpoint Research maintained E*TRADE Financial Corp (NASDAQ:ETFC) on Sunday, August 9 with "Hold" rating. Jefferies Group LLC reaffirmed a buy rating and set a $77.00 price objective (up from $55.00) on shares of Nucor Corporation in a research note on Tuesday, December 13th.
11/14/2016 - Nucor Corporation was downgraded to "hold" by analysts at Berenberg Bank. Longbow upgraded the stock to "Buy" rating in Monday, June 19 report. Argus Research maintained Nucor Corporation (NYSE:NUE) on Monday, December 12 with "Buy" rating. Washington Trust Bank boosted its position in shares of Nucor Corporation by 60.2% during the second quarter.
A number of other brokerages also recently weighed in on NUE. As per Wednesday, May 24, the company rating was maintained by Shore Capital.
In the market the company is trading up since yesterday's close of 53.6. As of the last earnings report the EPS was $3.56 and is projected to be $4.14 for the current year with 319,425,000 shares presently outstanding. Finally, Conning Inc. raised its stake in shares of Nucor Corporation by 1,764.7% in the third quarter. NUE's profit would be $338.57M giving it 12.64 P/E if the $1.06 EPS is correct. The company reported $0.50 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.34 by $0.16. It has outperformed by 5.04% the S&P500. Vanguard Group increased its position in Nucor Corporation by 1.3% in the Fiscal Q2.
Steel Dynamics (STLD) was down 0.3%, while U.S. Steel (X) dipped 1%.
Shares of Nucor Corporation closed the previous trading session at with shares trading hands. 241.22 million shares or 0.70% more from 239.54 million shares in 2016Q3 were reported.
Real Madrid keen to sign Arsenal star
City bid £60m for the Chile worldwide , with Arsenal waiting on Monaco sensation Thomas Lemar as a replacement for Sanchez. The forward helped Arsenal come from behind to beat Cologne 3-1 in the UEFA Europa League on Thursday with a sublime goal.
According to the the latest analyst ratings which have been released, 5 brokers have issued a rating of "buy", 4 brokers "outperform", 6 brokers "hold", 0 brokers "underperform" and 0 brokers "sell". 13,491 were accumulated by Nomura Inc. The institutional investor held 89,136 shares of the specialty insurers company at the end of 2016Q4, valued at $9.94M, down from 93,238 at the end of the previous reported quarter. Tradewinds Capital Limited Liability Corporation invested in 0.02% or 625 shares. Advantage Investment Management LLC boosted its position in shares of Nucor Corporation by 164.9% during the first quarter.
Luxor Capital Group Lp decreased Voya Finl Inc (VOYA) stake by 39.56% reported in 2016Q4 SEC filing. Qs Investors Limited Co holds 19,502 shares. Fil Limited, a Bermuda-based fund reported 19,164 shares.
On 2/15/2013 Nucor Corporation announced a quarterly dividend of $0.37. Busey Tru Co has invested 0.6% in Nucor Corporation (NYSE:NUE). 3,585 were accumulated by Hartford Financial Management.
Nucor Corporation manufactures steel and steel products.
The company now has a P/E ratio of 15.15 and the market cap of the company is 17.24B. The Company produces direct reduced iron (DRI) for use in its steel mills. It has a 14.72 P/E ratio.
NUE says its Louisiana plant has experienced unplanned outages for most of Q3, which will reduce Q3 earnings for the raw materials segment. Nucor Corporation has had 3 insider trades in the last 3 months, including 0 open market buys and 3 sells. Therefore 0 are positive. The firm has "Buy" rating by Jefferies given on Wednesday, September 16. The stock of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) earned "Neutral" rating by PiperJaffray on Wednesday, November 30. The firm earned "Hold" rating on Monday, April 24 by BMO Capital Markets. The firm earned "Hold" rating on Friday, July 22 by Berenberg. Advantage Investment Management LLC now owns 1,854 shares of the basic materials company's stock worth $111,000 after buying an additional 1,154 shares during the period. The firm has "Buy" rating given on Thursday, November 10 by Chardan Capital Markets.